Atropisomers with a biaryl dihydronaphthopyranone structure, dinapinones A1 (DPA1) (M position) and A2 (DPA2) (P position), were isolated from the fungus culture broth of Talaromyces Neutral lipids, including triacylglycerol (TG) and cholesteryl ester (CE), are the final storage forms of free long-chain fatty acids and cholesterol in mammals; these molecules are used for vital functions, such as membrane function, epidermal integrity, bile acid synthesis, lipoprotein trafficking and steroidogenesis 1 . However, excess cytoplasmic accumulation of neutral lipids is a significant risk factor for several disease pathologies, including diabetes, obesity, atherosclerosis and nonalcoholic fatty liver disease 2 . For example, the accumulation of CE causes macrophages in vessels to convert to foam cells, resulting in the development of atherosclerotic plaques and subsequent myocardial and cerebral infarction 3 . Similarly, the accumulation of TG in adipocytes can lead to obesity and thus contributes to fat formation in all obesity syndromes 4 . We are interested in discovering microbial inhibitors of neutral lipid synthesis/accumulation using a variety of cell-based assays with mouse peritoneal macrophages [5] [6] [7] [8] [9] [10] [11] [12] , Raji cells
. Structures of dinapinones. Dinapinones A1 and A2 are homodimers, and the others are heterodimers.
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IC 50 these cells probably do not provide reliable CE data. The cytotoxicity of DPA mix on all the cell lines tested above was tested by the MTT assay. As shown in Supplemental Fig. 1 , DPA mix did not show cytotoxicity, even after treatment with 12 μM for 6 h. Based on these findings, DPA mix affected neutral lipid synthesis and was more active toward TG synthesis than CE synthesis in mammalian cell lines. Further experiments were performed using CHO-K1 cells.
Effects of other atropisomers of DPs on neutral lipid synthesis in CHO-K1 cells. Since a 1:1 mixture of DPA1 and DPA2 completely inhibited neutral lipid synthesis, we next investigated whether other DPs exerted the same effect. Heterodimers of DPAB, DPAC, DPAD and DPAE consist of the atropisomers DPAB1, DPAC1, DPAD1, DPAE1 (1 series with the M position) DPAB2, DPAC2, DPAD2 and DPAE2 (2 series with the P position), respectively 21 ( Fig. 1 ). As shown in Table 2 , with the exception of DPAE1, the administration of the 1 series of DP alone did not show inhibitory effects, even at 11 -12 μM, whereas the administration of the 2 series of DP alone, with the exception of DPAC2, inhibited [ 14 C ]TG synthesis (IC 50 : 1.1-4.3 μM). These results were consistent with the outcomes for DPA. Interestingly, DPAE1 moderately inhibited [ 14 C ]TG synthesis (IC 50 : 4.8 μM), whereas DPAC2 showed no inhibitory activity. The discrepancy might be due to effects of different alkyl side chains at the C-3′ in the heterodimer form of DP on inhibitory activity. Furthermore, except for DPAC mix , 1:1 mixtures of the atropisomers of heterodimeric DPs (DPAB mix , DPAD mix and DPAE mix ) exhibited enhanced inhibitory activity on [ 14 heterodimeric DPs, DPAB mix exhibited the strongest inhibition of TG (IC 50 : 1.1 to 0.030 μM, 37-fold) and CE (IC 50 : >12 to 0.089 μM, >135-fold) synthesis. Thus, both atropisomers (M and P position) of a DP are essential for complete inhibition of neutral lipid synthesis in CHO-K1 cells. Therefore, subsequent studies of the mechanism of action were performed using DPA mix .
Effects of DPAmix on enzymes involved in neutral lipid synthesis in CHO-K1 cells. In mammals,
TG is synthesized by two major pathways: the glycerol-3-phosphate (G3P) pathway ( Supplementary Fig. 2a ) and the monoacylglycerol (MAG) pathway. In most cell types, including CHO-K1 cells, TG is mainly produced via the G3P pathway, whereas the MAG pathway is highly active in specific cell lines derived from the small intestine 23 . In the G3P pathway, lysophosphatidate (LPA, which is also known as acylglycerol-3-phosphate) is first synthesized from G3P and fatty acyl-CoA by glycerol-3-phosphate acyltransferase (GPAT). Next, phosphatidate (PA) is synthesized from LPA and fatty acyl-CoA by acyl-CoA:acylglycerol-3-phosphate acyltransferase (AGPAT). Then PA is dephosphorylated by phosphatidic acid phosphatase (PAP) to produce diacylglycerol (DG). Finally, TG is synthesized from DG and fatty acyl-CoA by diacylglycerol:acyl-CoA acyltransferase (DGAT). The direct effect of DPA mix on these enzymes in the G3P pathway was investigated using microsomes prepared from CHO-K1 cells as enzyme sources. As shown in Supplementary Fig. 2b , at the highest concentration of 12 μM, DPA mix showed 23% inhibition of GPAT, 15% inhibition of AGPAT, 6.3% inhibition of PAP and 18% inhibition of DGAT, indicating that the target of DPA mix is not an enzyme in the G3P pathway.
The other neutral lipid, CE, is synthesized from free cholesterol and fatty acyl-CoA by SOAT (also known as ACAT). Therefore, the effects of DPA mix on SOAT activity were investigated using microsomes prepared from CHO-K1 cells. As shown in Supplementary Fig. 2b , DPA mix had no effect on SOAT activity, even at 12 μM. Based on these data, DPA mix had no effects on neutral lipid synthesis in CHO-K1 cells.
Effects of DPAmix on autophagy flux. Since DPA mix enhanced neutral lipid degradation in CHO-K1 cells, two catabolic pathways, specifically lipolysis and autophagy (lipophagy), were regarded as a target of DPA mix . Lipolysis is the process by which TG is hydrolyzed to glycerol and free fatty acids, and it is highly active in adipocytes 25 . Catecholamines, such as noradrenaline, trigger the lipolysis cascade via the β-adrenergic receptor. However, β-receptors are not expressed in CHO cell lines. In fact, isoproterenol (40 μM) 26 , a β-receptor agonist, had no effects on neutral lipid-loaded CHO-K1 cells ( Supplementary Fig. 3 ). Autophagy is the pathway that degrades intracellular components, including protein aggregates and organelles such as lipid droplets and the mitochondria [27] [28] [29] . The process plays a critical role in the maintenance of cellular homeostasis. Upon autophagy induction, microtubule-associated protein light chain 3 (LC3) is recruited to the membrane of autophagosomes and conjugates with phosphatidylethanolamine (PE) to be converted to membrane-bound LC3-II 30 . Therefore, LC3-II is a protein marker of autophagy and is detected with immunoblotting. As shown in Fig. 4a , treatment of CHO-K1 cells with 0.12 μM DPA mix for 6 h markedly increased LC3-II levels, and the levels were constant in cells treated with 0.12-12 μM DPA mix . Conversely, approximately the same levels of LC3-I were observed in cells treated with 0 and 0.012 μM DPA mix , and the levels decreased in cells treated with 0.12-12 μM DPA mix . However, treatment with DPA1 or DPA2 alone only induced a slight increase in LC3-II levels in CHO-K1 cells. The increase in LC3-II levels induced by DPA mix is explained by two possibilities 31 . One possibility is that autophagosome formation is enhanced and autolysosomal degradation occurs. The other possibility is that autolysosomal degradation is inhibited when the docking of autophagosomes with lysosomes is inhibited or lysosomal hydrolase activities are inhibited. To examine the effects of DPA mix on autophagy flux, we performed two assays. First, the level of p62 (known as SQSTM1/sequestosome 1) was measured, because it is selectively incorporated into autophagosomes through direct binding to LC3 and is efficiently degraded by autophagy 32 . As shown in Fig. 4a , the p62 levels in CHO-K1 cells were markedly decreased in a dose-dependent manner after a 6 h treatment with DPA mix . Next, we performed an LC3 flux assay 31 . If cells are treated with lysosomotropic compounds such as chloroquine or bafilomycin A 1 (BafA 1 ), which inhibits acidification inside the lysosome or inhibits autophagosome-lysosome fusion, or with lysosomal proteases such as pepstatin A and E-64d, the degradation of LC3-II is blocked, resulting in the accumulation of LC3-II 33 . Accordingly, the differences in the level of LC3-II between samples in the presence or absence of lysosomal inhibitors represent the amount of LC3 that is delivered to lysosomes for degradation. As shown in Fig. 4b , the levels of LC3-II were increased by treatment of BafA 1 for 6 h. The levels were further increased in co-treatment with DPA mix , indicating that autophagic flux was increased (Fig. 4c) (Fig. 3a) . Furthermore, except for DPAC mix , 1:1 mixtures of the atropisomers of heterodimeric DPs (12 μM) also dose-dependently increased the LC3-II levels after 6 h of treatment (Fig. 4d) . DPAB mix induced the most potent increase in LC3-II levels, whereas DPAC mix showed almost no induction. These effects of DPs on autophagy markers correlated well with the results for neutral lipid synthesis in CHO-K1 cells (Table 2) . Thus, we concluded that DP mix enhanced the degradation of neutral lipids in CHO-K1 cells along with activating the autophagy pathway.
Discussion
DPs were originally isolated from the culture broth of the fungus T. pinophilus FKI-3864 and were determined to be inhibitors of neutral lipid ([ 14 Table 2 ). The lower the number of hydroxyl moieties in the alkyl side chains of DPs (3 in DPAB, 4 in DPA, 5 in DPAD and DPAE and 6 in DPAC), the more potent the inhibition of neutral lipid synthesis by (P) atropisomers. Based on these results, the number and position of hydroxyl moieties in alkyl side chains of DPs are responsible for the inhibitory effects on neutral lipid accumulation in CHO-K1 cells. In support of this hypothesis, vioxanthin (P) with methyl groups as an alkyl side chain lacking a hydroxyl moiety 34, 35 did not inhibit neutral lipid accumulation, even at 18 μM ( Supplementary Fig. 4a,b) .
Several cases in which a combination of two different molecules elicit synergistic biological activities have been noted. A well-known case is the use of a β-lactam and a β-lactamase inhibitor. The combination potentiates the antibacterial activity of β-lactam against β-lactam-resistant bacteria 36 . Recently, pentamidine, a drug used to treat leishmaniasis, was reported to enhance the antibacterial activity of antibiotics against gram-negative bacteria by disrupting the outer membrane, allowing antibiotics to enter the bacteria and promote cell death 37 . In these two cases, the targets of the two compounds differ. A combination of quinupristin and dalfopristin (w/w, 3:7), both of which are streptogramin antibiotics, show bactericidal activity by inhibiting protein synthesis 38 . The depsipeptide quinupristin binds a nearby site on the 50 S ribosomal subunit to prevent the elongation of polypeptides. The macrolide dalfopristin binds to the peptidyl transferase site in the 50 S ribosomal subunit, which inhibits the earliest process of peptide elongation and results in conformational changes in the 50 S ribosome to enhance the binding of quinupristin to the ribosome. These compounds act on the same target, but at different sites. DP cases are very unusual, and a combination of atropisomers exhibits synergistic inhibition of neutral lipid accumulation in mammalian cells.
We chose DPA as a representative DP and investigated the mechanism of action of DPA mix on lipid metabolism in CHO-K1 cells to obtain a better understanding of this unusual biological activity of DPs. Unexpectedly, DPA mix showed almost no inhibitory effects on enzymes involved in the TG biosynthetic pathway and SOAT involved in the CE biosynthetic pathway, even at 12 μM (Supplementary Fig. 2b ). Of course, DPA1 and DPA2 alone did not affect these enzymes. Other possibilities of affecting both TG and CE synthesis are the inhibition of [ neutral lipid degradation experiment (Fig. 3a) , the cells were treated with [ 14 
the neutral lipid synthesis experiment, respectively. Because of this reason, it is suggested that the inhibitory activity of DPA mix was decreased.
These findings prompted us to investigate the involvement of autophagy to understand the actions of DPA mix . As expected, LC3-II, a well-known autophagy biomarker, was clearly observed in CHO-K1 cells treated with 0.12 μM DPA mix for 6 h (Fig. 4a) and in CHO-K1 cells treated with 12 μM DPA mix for 1 h (Fig. 4c) , indicating that DPA mix is a very potent inducer of autophagy. DPA1 or DPA2 alone had little ability to induce LC3-II expression (Fig. 4a) . Furthermore, p62, another marker of autophagy, was degraded in a dose-(0.012-12 μM DPA mix ) and time-dependent (0-6 h in the presence of 12 μM DPA mix ) manner (Figs 4a,c) . Notably, the LT 50 of p62 levels (3) (4) Fig. 5 ). The inhibition of mTOR by rapamycin may also affect pathways other than autophagy 43 . Based on this result, the target of DPA mix in the autophagy pathway might not be a component of the mTOR pathway. Furthermore, we have not clearly determined whether DPA1 and DPA2 act on different targets or different sites on the same target and how DPA mix exerts a synergistic effect on the autophagy pathway. In this study, DPA mix enhanced neutral lipid degradation along with induction of autophagy. Further studies are necessary to clarify the mechanism of action of DPA mix .
Preparation of microsomes from CHO-K1 cells. CHO-K1 cells (2 × 10
8 cells) were homogenized in 10 ml of Buffer A (100 mM sucrose, 50 mM KCl, 40 mM KH 2 PO 4 and 30 mM EDTA•4 Na, pH 7.2) supplemented with a protease inhibitor cocktail (Complete mini (Roche)) using a Teflon homogenizer. The microsomal fraction was pelleted by centrifugation at 100,000 × g for 1 h at 4 °C, resuspended in the same buffer at a concentration of 5.0 mg/ml protein and stored at −80 °C until use.
Assay of GPAT and AGPAT activities in microsomes prepared from CHO-K1 cells. GPAT and AGPAT activities were determined as previously described 46 , with a slight modification. Briefly, an assay mixture Assay of lipid droplet degradation in CHO-K1 cells using oil red O staining. The assay of lipid droplet degradation in CHO-K1 cells was conducted using a previously described method 49 , with slight modifications. Briefly, CHO-K1 cells (2 × 10 5 cells) were cultured in 35 mm dishes (Techno Plastic Products AG, Trasadingen, Switzerland) on a glass coverslip coated with poly L-lysine in 2.0 ml of medium A and allowed to recover overnight at 37 °C in 5.0% CO 2 . Following the overnight recovery, 20 μM oleic acid was added to each dish and incubated for 12 h to allow lipid droplets to accumulate in cells. Then, the medium was removed, and the cells in each well were washed twice with Buffer B containing 2.0 mg/ml BSA, washed again with Buffer B and subsequently incubated with 2 ml of fresh medium lacking oleic acid in the presence of either DPA mix (20 μl of methanol solution) or methanol. After 0 and 6 h of incubation, cells were washed with PBS and then fixed by immersion in 10% formalin. Nuclei and intracellular neutral lipid droplets were then stained with hematoxylin and oil red O, respectively. Lipid droplet formation and morphological changes in CHO-K1 cells were examined using a confocal laser-scanning microscope (LSM-510 META, Carl Zeiss, Oberkochen, Germany).
MTT assay. Assay for cytotoxic activity using CHO cells was carried out by our established method 19 . Briefly, cytotoxicity of a sample to CHO cells was measured by the colorimetric assay on MTT. CHO cells (5.0 × 10 4 cells in 100 μl) were added to each well of a 96-well microplate. A sample (1.0 μl in MeOH) was added to each well, and the cells were incubated for 12 h at 37 °C. MTT (10 μl of 5.5 mg ml −1 stock solution) and a cell lysate solution (90 μl, 40% N, N-dimethylformamide, 20% sodium dodecyl sulfate, 2.0% CH 3 COOH and 0.030% HCl) were added to each well, and the microplate was shaken for 2 h. The optical density (OD) of each well was measured at 540 nm using a microtiter-plate reader (Elx 808; BioTek Instruments, Winooski, VT, USA). Western blot analysis of autophagy-related proteins in CHO-K1 cells. CHO-K1 cells (1.25 × 10 5 cells) were cultured in each well of a 12-well plastic microplate (Corning Co.) in 1.0 ml of medium A and allowed to recover overnight at 37 °C in 5.0% CO 2 . Following the overnight recovery, a test sample was added to each well of the culture. After an incubation at 37 °C in 5.0% CO 2 , cells in each well were washed twice with PBS and detached with trypsin. After centrifugation at 500 x g for 10 min, cells were incubated with cold lysis buffer (50 mM Tris-HCl (pH 7.2), 250 mM NaCl, 0.10% Nonidet P-40, 2.0 mM EDTA and 10% glycerol) containing a protease cocktail inhibitor. After 30 min of incubation on ice, lysates were centrifuged at 12,000 x g for 10 min at 4 °C, and an equal amount of 2x Laemmli sample buffer containing 2.0% 2-mercaptoethanol was added to each supernatant, which was boiled for 5 min and centrifuged. A portion of the supernatant was separated by SDS-PAGE at a constant current of 20 mA for 1.5 h. Proteins were transferred to polyvinylidene difluoride membranes (PVDF, Immobilon-P, Millipore, USA) for 1 h at 100 V using a Western blot apparatus (MODEL BE-350, BIO CRAFT, Japan). After transfer, the PVDF membrane was blocked in 5.0% skim milk in TBS-T buffer (20 mM Tris-HCl (pH 7.4), 100 mM NaCl and 0.10% (v/v) Tween 20) for 1 h at room temperature. The PVDF membrane was washed with TBS-T buffer and then incubated with a primary antibody (anti-LC3, anti-p62, or β-actin at a 1:2500, 1:1000 or 1:10000 dilution, respectively) in TBS-T buffer for 1 h at room temperature. The primary antibody was then removed, and the PVDF membrane was washed and incubated with a secondary antibody for 1 h. After removing the secondary antibody, the blot was visualized using ECL Western Blotting Detection Reagents (GE Healthcare, Pittsburgh, USA) and detected using a LAS-4000 mini with Science Lab 2005 software (Fujifilm Co., Japan).
